These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9064953)

  • 41. [Ventricular tachycardia in anterior wall aneurysm after myocardial infarct].
    Bach P; Gonschior P; Prinz C; Kreuzer E; Autenrieth G; Steinbeck G
    Internist (Berl); 1992 Nov; 33(11):758-62. PubMed ID: 1478832
    [No Abstract]   [Full Text] [Related]  

  • 42. Effect of amiodarone on the descending limb of the T wave.
    Smetana P; Pueyo E; Hnatkova K; Batchvarov V; Camm AJ; Malik M
    Am J Cardiol; 2003 Sep; 92(6):742-6. PubMed ID: 12972125
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The European Myocardial Infarct Amiodarone Trial (EMIAT). EMIAT Investigators.
    Camm AJ; Julian D; Janse G; Munoz A; Schwartz P; Simon P; Frangin G
    Am J Cardiol; 1993 Nov; 72(16):95F-98F. PubMed ID: 8237837
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Does amiodarone reduce sudden death and cardiac mortality after myocardial infarction? The European Myocardial Infarct Amiodarone Trial (EMIAT).
    Schwartz PJ; Camm AJ; Frangin G; Janse MJ; Julian DG; Simon P
    Eur Heart J; 1994 May; 15(5):620-4. PubMed ID: 8056000
    [No Abstract]   [Full Text] [Related]  

  • 45. Beta-blocker prevention of proarrhythmia and proischemia: clues from CAST, CAMIAT, and EMIAT. Cardiac Arrhythmia Suppression Trial. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial. European Myocardial Infarct Amiodarone Trial.
    Kennedy HL
    Am J Cardiol; 1997 Nov; 80(9):1208-11. PubMed ID: 9359552
    [No Abstract]   [Full Text] [Related]  

  • 46. [Implantable automatic defibrillator after MADIT and EMIAT].
    Farré J
    Rev Esp Cardiol; 1996 Oct; 49(10):709-13. PubMed ID: 9036472
    [No Abstract]   [Full Text] [Related]  

  • 47. Major clinical trials assessing the prophylactic use of amiodarone in patients with ventricular tachyarrhythmias.
    Fogoros RN
    Control Clin Trials; 1996 Jun; 17(3 Suppl):37S-46S. PubMed ID: 8877266
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Class I anti-arrhythmia agents and prevention of sudden death following myocardial infarction].
    Boissel JP; Lièvre M; Rosenberg Y
    Arch Mal Coeur Vaiss; 1991 Feb; 84 Spec No 2():49-54. PubMed ID: 1669239
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial (CAMIAT): rationale and protocol. CAMIAT Investigators.
    Cairns JA; Connolly SJ; Roberts R; Gent M
    Am J Cardiol; 1993 Nov; 72(16):87F-94F. PubMed ID: 8237836
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Amiodarone after myocardial infarction: EMIAT and CAMIAT trials.
    Pinski SL
    Lancet; 1997 Jun; 349(9067):1768-9; author reply 1769-70. PubMed ID: 9193400
    [No Abstract]   [Full Text] [Related]  

  • 51. Amiodarone after myocardial infarction: EMIAT and CAMIAT trials.
    Malik M; Camm AJ
    Lancet; 1997 Jun; 349(9067):1767-8. PubMed ID: 9193398
    [No Abstract]   [Full Text] [Related]  

  • 52. Meta-analysis of antiarrhythmic drug trials.
    Connolly SJ
    Am J Cardiol; 1999 Nov; 84(9A):90R-93R. PubMed ID: 10568666
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Poor adherence to placebo or amiodarone therapy predicts mortality: results from the CAMIAT study. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial.
    Irvine J; Baker B; Smith J; Jandciu S; Paquette M; Cairns J; Connolly S; Roberts R; Gent M; Dorian P
    Psychosom Med; 1999; 61(4):566-75. PubMed ID: 10443767
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Amiodarone after myocardial infarction: EMIAT and CAMIAT trials.
    Norris RM
    Lancet; 1997 Jun; 349(9067):1767. PubMed ID: 9193396
    [No Abstract]   [Full Text] [Related]  

  • 55. Identification of post acute myocardial infarction patients with potential benefit from prophylactic treatment with amiodarone. A substudy of EMIAT (the European Myocardial Infarct Amiodarone Trial).
    Janse MJ; Malik M; Camm AJ; Julian DG; Frangin GA; Schwartz PJ
    Eur Heart J; 1998 Jan; 19(1):85-95. PubMed ID: 9503180
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Amiodarone after myocardial infarction: EMIAT and CAMIAT trials.
    Incalzi RA; Gemma A; Carbonin PU
    Lancet; 1997 Jun; 349(9067):1768; author reply 1769-70. PubMed ID: 9193399
    [No Abstract]   [Full Text] [Related]  

  • 57. Holter monitoring as valuable as EPS testing.
    Can J Cardiol; 1993 Oct; 9(8):687-8. PubMed ID: 8269354
    [No Abstract]   [Full Text] [Related]  

  • 58. Post-myocardial infarction mortality in patients with ventricular premature depolarizations. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Pilot Study.
    Cairns JA; Connolly SJ; Gent M; Roberts R
    Circulation; 1991 Aug; 84(2):550-7. PubMed ID: 1860199
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Amiodarone after myocardial infarction: EMIAT and CAMIAT trials.
    Cleland JG; Erhardt L
    Lancet; 1997 Jun; 349(9067):1767. PubMed ID: 9193397
    [No Abstract]   [Full Text] [Related]  

  • 60. Effect of amiodarone therapy on mortality in patients with left ventricular dysfunction and asymptomatic complex ventricular arrhythmias: Argentine Pilot Study of Sudden Death and Amiodarone (EPAMSA).
    Garguichevich JJ; Ramos JL; Gambarte A; Gentile A; Hauad S; Scapin O; Sirena J; Tibaldi M; Toplikar J
    Am Heart J; 1995 Sep; 130(3 Pt 1):494-500. PubMed ID: 7661066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.